ESPEROVAX

Welcome to the Brand page for “ESPEROVAX”, which is offered here for Vaccines; oral vaccines; modified cells for medical or clinical use; pharmaceuticals in the nature of yeast-based pharmaceuticals; oral vaccine preparations; pharmaceutical products for the treatment of infectious diseases; recombinant yeast-based pharmaceutical products; yeast-based oral vaccines; pharmaceutical preparations, a drug delivery system comprising yeast-based oral vaccines; pharmaceutical products, yeast-based oral vaccines; biological and pharmaceutical preparations, recombinant yeast for medical use;medical research in the field of vaccines and medicines; research and development of vaccines and medicines; research and development in the pharmaceutical and biotechnology fields; scientific research in the field of vaccines and medicines; pharmaceutical research and development; research and development in the field of immunology; research and development in the field of microorganisms, research and development related to yeast; research and development in the field of therapeutics; development of pharmaceutical preparations and medicines; scientific study and research in the field of medicine; scientific study and research in the field of healthcare products; medical and scientific research; discovery, development and design of pharmaceutical and therapeutic preparations; pharmaceutical, biologic, and vaccine research and development;.

Its status is currently believed to be active. Its class is unavailable. “ESPEROVAX” is believed to be currently owned by “Esperovax, Inc.”